Nephros (NEPH) Change in Account Payables (2014 - 2026)
Nephros (NEPH) posted quarterly Change in Account Payables of $562000.0 for Q1 2026, up 635.24% year-over-year from $76437.8 in Q1 2025, and up 2037.93% quarter-over-quarter from -$29000.0 in Q4 2025.
Nephros (NEPH) Change in Account Payables (2014 - 2026) Analysis & Trends
Nephros' Change in Account Payables history runs 13 years deep, the most recent figure standing at $562000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 635.24% year-over-year to $562000.0; the TTM figure through Mar 2026 stood at $926000.0 (up 262.74% YoY), while the FY2025 annual figure was $259000.0, up 217.73% from the prior year.
- Change in Account Payables for Q1 2026 stood at $562000.0, up from -$29000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $562000.0 in Q1 2026, with the low at -$766000.0 in Q3 2024.
- The 5-year median for Change in Account Payables is $45000.0 (2024), against an average of $8294.1.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables slumped 675.0% in 2022, then jumped 1261.9% in 2024.
- Nephros' Change in Account Payables stood at -$38000.0 in 2022, then surged by 278.95% to $68000.0 in 2023, then surged by 277.94% to $257000.0 in 2024, then slumped by 111.28% to -$29000.0 in 2025, then soared by 2037.93% to $562000.0 in 2026.
- Business Quant data shows NEPH's Change in Account Payables at $562000.0 in Q1 2026, -$29000.0 in Q4 2025, and $312000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -52.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 83.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -17.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -52.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 499,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 499,000.00 |
| Jun 30, 2026 | 499,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | -105,000.00 |
| Mar 31, 2025 | -105,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | -766,000.00 |
| Sep 30, 2024 | -766,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Mar 31, 2024 | 244,000.00 |